A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 25 shares of XBI stock, worth $2,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$2,460
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$82.22 - $94.12 $2,055 - $2,353
25 New
25 $2,000
Q3 2023

Nov 09, 2023

SELL
$71.88 - $85.76 $120,470 - $143,733
-1,676 Reduced 31.52%
3,641 $265,000
Q2 2023

Aug 08, 2023

SELL
$75.38 - $90.23 $196,892 - $235,680
-2,612 Reduced 32.94%
5,317 $442,000
Q1 2023

Jun 20, 2023

SELL
$73.13 - $91.97 $1.53 Million - $1.92 Million
-20,862 Reduced 72.46%
7,929 $604,000
Q4 2022

Mar 02, 2023

BUY
$76.72 - $85.66 $1.96 Million - $2.19 Million
25,589 Added 799.16%
28,791 $2.39 Million
Q3 2022

Nov 15, 2022

BUY
$75.06 - $94.9 $14,711 - $18,600
196 Added 6.52%
3,202 $254,000
Q2 2022

Aug 16, 2022

BUY
$62.81 - $96.09 $188,806 - $288,846
3,006 New
3,006 $223,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.